Our missions

Feasability Study – Implementation of new process on existing or new sites


The world’s leading radiopharmaceutical company has obtained a licence in the US for a new tracer for PETscan produced by a cyclotron. In order to prepare for deployment in Europe, the company commissioned a conceptual design to compare five possible options (greenfield/revamping) on sites it owns.


In partnership with an engineering company, ILS analysed the sites under consideration and proposed plans for each option (layout, flows, utilities), a list of equipment, a global budget and a schedule. These data were used to build a comparison matrix based on financial, operational, logistical and regulatory aspects, which was presented to the client.

The mission




API / Fill & Finish


France & Europe


1-3 months



Investment cost

10 - 50 M€

Contact us

Whether you need help with a Life Science project or you’d like to know more about us, we’d love to hear from you.

    By completing and submitting this form, you agree that the information collected will be used in the context of the contact request and the commercial relationship that may result.

    * required fields

    You have the right to access, rectify and delete your personal data.
    See our privacy policy for details.